Find a Physician | How to Contribute | Contact Us | Clinical Trials
Search: 
Select a Cancer Type:

Magellan Development Half Marathon and 10K to Benefit Northwestern Brain Tumor Institute

June 2010

Northwestern Brain Tumor Institute has been selected by Magellan Development Group as their charity partner for the Magellan Development Chicago Spring Half Marathon and 10K Race. Funds raised will support the recently launched Northwestern Brain Tumor Institute and its programs. The race takes place at 7:00 am on Sunday, May 16 in the Park at Lakeshore East, located just north of Millennium Park at Field Drive and Randolph Street.

We are very grateful for the support of Magellan and the race organizers," said James Chandler, MD, Surgical Director of neuro-oncology and co-director of the NBTI. "It is imperative that we increase awareness of brain cancer and raise funds to support life-saving research and clinical trials so we can find better treatment options and ultimately, a cure." Hospital staff and support group members plan to participate in the race. Among the participants are medical director of neuro-oncology and co-director of the Institute Jeffrey Raizer, MD, director of research Marcus Bredel, MD, PhD, and Chandler. "I look forward to participating on behalf of my patients as we have to support those who support us; I'll be thinking of their determination as I train for and run this race," said Raizer.

"Magellan chose to support NBTI when my husband was diagnosed at the hospital," said Robin Loewenberg Berger, Chief Marketing Officer of Magellan Development and co-chair of the event. "We want to raise awareness of this vital program and have created several VIP Charity Sponsorship opportunities."

Runners will be able to dedicate their race experience to the fight against brain cancer. They can register online, start their own teams to raise money for the Institute and encourage friends and family members to contribute to the cause. FOX News entertainment reporter Bill Zwecker will serve as master of ceremonies on race day for VIP pre- and post-race events.

For NBTI patient Jose Feliciano, the race is personal. Feliciano is an avid runner who logs an average of 15-20 miles each week and was diagnosed with a brain tumor two years ago. "My wife jokes that I’m running away from my problems, but running clears my head and gives me back a sense of control," said Feliciano. "This year I look forward to encouraging my friends and family to participate in the race with me." Feliciano will be running the race in honor of all NBTI patients and the members of Northwestern’s Brain Tumor Support Group. Group members will be spread out throughout the course to cheer him on.

The goal of the Institute is to be able to help patients like Feliciano, no matter where the individual is on the disease spectrum. Both Chandler and Raizer agree that the Institute's objective is to offer meaningful treatment options to patients in any stage of disease, and for patients to know that their treatment and care is the best that exists in medicine.

About the Northwestern Brain Tumor Institute
The Institute merges clinical research with medical and surgical treatment for brain and spinal tumor patients. It is a collaboration between the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital. To learn more about the Northwestern Brain Tumor Institute including information on fundraising teams and VIP Charity Sponsorships, visit http://www.braintumorinstitute.org.

About Magellan Development Group
Magellan Development Group is a Chicago-based development company committed to creating premier, environmentally-sensitive urban communities that combine innovative architectural design with high-quality construction. The company's primary development, Lakeshore East, resides in the New East Side neighborhood of Chicago and includes the award-winning new mixed-use tower, Aqua. To learn more about Magellan Development Group or Aqua at Lakeshore East, visit http://www.magellandevelopment.com.

(Last updated on June 21, 2013 )